title: [Clinical analysis of patients with recurrences of borderline ovarian tumors including surgical treatment].
abstract: OBJECTIVE
  Risk of recurrences of borderline ovarian tumors is low (7-10%) but the cases with incidence of recurrence have worse prognosis. The time between primary operation and the first diagnosis of recurrence and treatment is different.
  
  
  METHODS
  The purpose of the current study was to evaluate frequency and the methods of treatment patients with recurrences of borderline ovarian tumors.
  
  
  METHODS
  The analyzing group consists of 129 patients with borderline tumors of the ovary (BTO) diagnosed and treated in Department of Gynecology between years 1978-2000.
  
  
  RESULTS
  In our recurrences developed in 7% of patients. The recurrences in BTO were connected with stage of BTO, types of primary operations and residual disease. Recurrences developed in 5,9% patients with stage I and in 18,1% patients with stage II/III. Similarly recurrences developed in 5,8% patients with no residual disease and in 20% patient with residual disease. A higher relapse rate was observed in patients treated conservatively but recurrences was quickly recognized and efficaciously treated. 5 years survival of patients without recurrences was 91,7% and with recurrences was 72,9%.
  
  
  CONCLUSIONS
  1. Risk of recurrences of BTO is low (7%) and depends on stage and residual disease. 2. Risk of recurrences is higher after primary conservative operation but long follow-up and regular gynecological examinations allows to early diagnosis and treatment of recurrences. 3. Prognosis of patients with recurrences of BTO is good. 5-years survival was 90,6% of group without and 72,9% of group with recurrences of BTO.
authors.affiliation: Klinika Ginakologii Instytutu Połoznictwa i Chorób Kobiecych, Akademii Medycznej w Gdańsku. holsz@pro-femina.com
authors.forename: Hanna
authors.initials: H
authors.lastname: Olszewska
authors.forename: Maciej
authors.initials: M
authors.lastname: Stukan
authors.forename: Janusz
authors.initials: J
authors.lastname: Emerich
mesh_terms: D000368:Aged; D018282:Cystadenocarcinoma, Mucinous / Q000473:pathology / Q000601:surgery*; D018284:Cystadenocarcinoma, Serous / Q000473:pathology / Q000601:surgery*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000473:pathology / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000473:pathology / Q000601:surgery*; D011044:Poland; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome